newsfilter
← Latest News
GlobeNewswire·

Artelo Biosciences Announces Pricing of $2.0 Million Public Offering

SOLANA BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people